(Q33914241)

30 July 2017

1 reference

title

Donepezil: a review of its use in Alzheimer's disease (English)

1 reference

30 July 2017

Dooley M

1

1 reference

PubMed ID

10803860

30 July 2017

Lamb HM

series ordinal

2

1 reference

30 July 2017

1 March 2000

1 reference

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

199-226

1 reference

30 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200016030-00005

30 July 2017

0 references

cites work

Realistic expectations for the management of Alzheimer's disease

1 reference

12 December 2020

Donepezil: an anticholinesterase inhibitor for Alzheimer's disease.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

12 December 2020

The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin

1 reference

12 December 2020

Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.

1 reference

12 December 2020

Donepezil use in Alzheimer disease

1 reference

12 December 2020

Donepezil. Pharmacoeconomic implications of therapy

1 reference

12 December 2020

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

12 December 2020

Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers

1 reference

12 December 2020

Recent developments in the drug treatment of Alzheimer's disease

1 reference

12 December 2020

Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

12 December 2020

Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

Early identification of Alzheimer's disease and related dementias. Early Identification of Alzheimer's Disease and Related Dementias Panel

1 reference

12 December 2020

Drug treatment of Alzheimer's disease. Effects on caregiver burden and patient quality of life

1 reference

12 December 2020

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

1 reference

12 December 2020

Concurrent administration of donepezil HCl and digoxin: assessment of pharmacokinetic changes

1 reference

12 December 2020

Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor.

1 reference

12 December 2020

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

1 reference

12 December 2020

An evaluation of the pharmacokinetics of donepezil HCl in patients with impaired hepatic function

1 reference

12 December 2020

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

Guidelines on drug treatments for Alzheimer's disease.

1 reference

12 December 2020

Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020.

1 reference

12 December 2020

Cholinergic improvement of a naturally-occurring memory deficit in the young rat.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration

1 reference

12 December 2020

Clinical profile of donepezil in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Rivastigmine. A review of its use in Alzheimer's disease.

1 reference

12 December 2020

An evaluation of the pharmacokinetics of donepezil HCl in patients with moderately to severely impaired renal function

1 reference

12 December 2020

Clinical benefits of a new piperidine-class AChE inhibitor

1 reference

12 December 2020

Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.

1 reference

12 December 2020

Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.

1 reference

12 December 2020

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

1 reference

12 December 2020

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

1 reference

12 December 2020

Cognitive enhancement therapy for Alzheimer's disease. The way forward

1 reference

12 December 2020

Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.

1 reference

12 December 2020

New drugs for Alzheimer's disease

1 reference

12 December 2020

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

1 reference

12 December 2020

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

12 December 2020

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

12 December 2020

Butyrylcholinesterase in the life cycle of amyloid plaques.

1 reference

12 December 2020

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association

1 reference

12 December 2020

Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

12 December 2020

Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia

1 reference

12 December 2020

Neuropathobiology of senile dementia and mechanism of action of nootropic drugs

1 reference

12 December 2020

Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats

1 reference

12 December 2020

Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

1 reference

12 December 2020

Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects

1 reference

12 December 2020

10.2165/00002512-200016030-00005

Identifiers

DOI

1 reference

PubMed ID

10803860

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10803860